title: Cyclosporine modulation of multidrug resistance in combination with pravastatin, mitoxantrone and etoposide for adult patients with relapsed/refractory acute myeloid leukemia: a phase 1/2 study.
authors: Pharmacy Services, University of Washington Medical Center , Seattle, WA , USA.
authors: Tara L
authors: TL
authors: Chen
authors: Elihu H
authors: EH
authors: Estey
authors: Megan
authors: M
authors: Othus
authors: Kelda M
authors: KM
authors: Gardner
authors: Lauren J
authors: LJ
authors: Markle
authors: Roland B
authors: RB
authors: Walter
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D016572:Cyclosporine / Q000009:adverse effects; D018432:Drug Resistance, Multiple; D019008:Drug Resistance, Neoplasm; D005047:Etoposide / Q000008:administration & dosage; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008942:Mitoxantrone / Q000008:administration & dosage; D017035:Pravastatin / Q000008:administration & dosage; D016896:Treatment Outcome
chemical_list: D005047:Etoposide; D016572:Cyclosporine; D008942:Mitoxantrone; D017035:Pravastatin